Guide for patients & caregivers
Positive Mycoplasma Genitalium Test: What Happens Next?
Tested positive for Mycoplasma genitalium? Learn why antibiotic resistance shapes treatment, when a test of cure is used, and what partners need to know.
Prepared with AI assistance and checked against the cited sources. No independent clinician review has been completed. How we prepare articles
What does a positive Mycoplasma genitalium test mean?
A positive Mycoplasma genitalium test means a laboratory test, usually on urine or a genital swab, found genetic material from this bacterium. The CDC describes Mgen as a common sexually transmitted infection that can be cured with the right antibiotics, although many people have no symptoms.
The test is a nucleic acid amplification test (NAAT), which detects the bacterium's genetic material. One NHS laboratory notes that its test is validated for male urine samples and vaginal swabs, which can often be self-taken, and that urine samples from women are less sensitive.
This is a different organism from Mycoplasma pneumoniae, which causes chest infections and is checked with a separate blood antibody test. This guide gives general information only. Your sexual health clinic or clinician will decide on treatment, and this guide gives no doses.
Get checked sooner: symptoms that need prompt care
Seek emergency care for sudden, severe pain in the testicles or tummy; the NHS advises A&E or an emergency call for sudden, unbearable testicle pain. If you are or could be pregnant, call emergency services for sudden, intense tummy pain with feeling very dizzy, fainting or looking very pale, which the NHS lists as signs of a possible ruptured ectopic pregnancy.
Arrange a prompt appointment if you have possible signs of pelvic inflammatory disease (PID) or other complications:
- pain in the lower tummy, or fever
- pain or bleeding during sex, or bleeding between periods
- an unusual, bad-smelling discharge
- swelling or aching in a testicle
- symptoms that continue for more than a few days after finishing treatment
Why does Mycoplasma genitalium matter if I feel fine?
In men, Mgen can cause urethritis, which is inflammation of the tube that carries urine. In women, it can cause cervicitis and is linked to PID. The CDC says that untreated infection in women can lead to PID, with possible scarring of the fallopian tubes, ectopic pregnancy, infertility and long-term pelvic pain. It may also be linked to early birth or pregnancy loss. The CDC states it is not known whether men develop long-term problems.
The CDC does not recommend routine screening of people without symptoms. Testing is usually done for persistent or recurring symptoms, PID or a partner's positive result. If you were tested without symptoms, ask why, as that can shape what the clinic advises next.
Why is treatment resistance a concern?
Mgen has no cell wall, so antibiotics such as penicillins that target cell walls do not work against it, according to the CDC. It has also become resistant to some antibiotics often used for other sexually transmitted infections.
The CDC reports that markers of resistance to macrolide antibiotics are found in 44% to 90% of infections across the United States, Canada, Western Europe and Australia. In England, UK Health Security Agency surveillance found macrolide resistance markers in 65.5% of tested samples in 2025, and fluoroquinolone resistance markers in 20.2%. Figures vary by country and over time.
This is why clinics may ask about previous antibiotic treatment and why finishing the course as prescribed matters.
Some laboratories can check a positive sample for markers of antibiotic resistance. The CDC advises using resistance testing where it is available, because the result helps guide the choice of treatment. It is worth asking whether this was done on your sample and, if not, how the clinic will choose treatment.
How is Mycoplasma genitalium treated?
Both the CDC and UK guidance describe a resistance-guided, two-step approach. A first antibiotic lowers the amount of bacteria, then a second antibiotic is chosen according to whether the infection carries macrolide resistance markers, where that test is available. The CDC reports cure rates above 90% with this approach when resistance testing is used.
The specific medicines, order and length of treatment are for your clinician to decide. Take any medicine as prescribed, finish the course and do not share antibiotics. Do not stop or change a prescribed medicine without speaking to the prescriber. Tell the clinic about any side effects, pregnancy or other medicines you take.
Do I need a test of cure?
Advice on this has changed. The CDC states that a test of cure is not recommended for people without symptoms who received a recommended treatment. The UK Health Security Agency's 2025 surveillance report notes that 2025 UK guidelines no longer recommend a test of cure for people whose symptoms have gone.
A retest may still be used in some situations, such as when symptoms continue, when a less established treatment was used or when the clinic is following local policy. The CDC advises returning to a clinician if symptoms continue more than a few days after finishing treatment. Ask your clinic whether a retest is planned for you, and when.
What about my partner?
The CDC advises that sex partners should see a clinician who can test and treat them if needed. UK surveillance guidance also notes testing is recommended for current partners of people with Mgen. CDC treatment guidelines add that partners who test positive can be treated, and that where partner testing is not possible, a clinician may offer the partner the same treatment.
To avoid passing the infection back and forth, the CDC advises waiting until you and your partners have finished treatment and symptoms have gone before having sex again. You can get Mgen again after treatment, and condoms lower the risk.
Questions to ask your clinician
These questions can help you understand your plan:
- Was a resistance test done on my sample, and what did it show?
- Which other infections were tested for at the same time?
- How long should I avoid sex, and when can my partner be seen?
- Will I need a retest, and if so, when?
- What should I do if symptoms continue after treatment?
- Does this result affect a current or planned pregnancy?
How SameCase can help you prepare
On SameCase, patients and verified doctors share de-identified cases. Seeing how others with a positive Mgen result discussed resistance testing or partner follow-up can help you prepare questions. Other people's cases cannot diagnose you or predict your outcome, and we do not give treatment advice. Your clinic remains responsible for your care.
Sources and further reading
- CDC: About Mycoplasma genitalium (January 2025)
- CDC: Mycoplasma genitalium, STI Treatment Guidelines 2021
- UK Health Security Agency (GOV.UK): Mycoplasma genitalium antimicrobial resistance surveillance (MARS) report, 2025
- CDC: About pelvic inflammatory disease
- NHS: Ectopic pregnancy
- NHS: Epididymitis
- Gloucestershire Hospitals NHS: Mycoplasma genitalium PCR test information
For patients & caregivers
Share your case and learn from others
Learn from doctors and other people's cases to find a way forward with your health problem. New cases are public immediately. Don't add names or identifying details.